Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
134.42
-0.01 (-0.01%)
Jan 22, 2025, 4:00 PM EST - Market closed
Tenet Healthcare Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for Tenet Healthcare stock have an average target of 165.56, with a low estimate of 122 and a high estimate of 217. The average target predicts an increase of 23.17% from the current stock price of 134.42.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for THC stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 6 | 5 | 5 |
| Buy | 8 | 8 | 9 | 8 | 9 | 10 |
| Hold | 1 | 1 | 1 | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 18 | 16 | 17 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Keybanc | Keybanc | Buy Maintains $200 → $185 | Buy | Maintains | $200 → $185 | +37.63% | Jan 7, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $190 → $175 | Strong Buy | Maintains | $190 → $175 | +30.19% | Jan 6, 2025 |
| JP Morgan | JP Morgan | Buy Initiates $175 | Buy | Initiates | $175 | +30.19% | Dec 17, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $196 → $140 | Strong Buy → Hold | Downgrades | $196 → $140 | +4.15% | Dec 16, 2024 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $205 → $150 | Buy → Hold | Downgrades | $205 → $150 | +11.59% | Nov 25, 2024 |
Financial Forecast
Revenue This Year
21.04B
from 20.55B
Increased by 2.39%
Revenue Next Year
21.56B
from 21.04B
Increased by 2.45%
EPS This Year
11.24
from 5.71
Increased by 96.92%
EPS Next Year
11.52
from 11.24
Increased by 2.53%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 22.6B | 23.6B | 24.1B | |||
| Avg | 21.0B | 21.6B | 22.5B | |||
| Low | 20.2B | 20.3B | 21.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 10.1% | 12.2% | 12.0% | |||
| Avg | 2.4% | 2.5% | 4.6% | |||
| Low | -1.5% | -3.5% | -1.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 12.25 | 13.65 | 15.62 | |||
| Avg | 11.24 | 11.52 | 13.08 | |||
| Low | 8.72 | 9.20 | 10.55 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 114.7% | 21.5% | 35.6% | |||
| Avg | 96.9% | 2.5% | 13.5% | |||
| Low | 52.9% | -18.1% | -8.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.